Legal & General Group PLC Mereo Biopharma Group PLC Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.33 - $1.69 $17,219 - $88,182	-52,179 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.59 $48,119 - $82,535	31,867 Added 156.89%	52,179 $84,000
Q3 2021 Nov 15, 2021	BUY	$2.2 - $3.17 $10,109 - $14,566	4,595 Added 29.24%	20,312 $49,000
Q2 2021 Aug 12, 2021	BUY	$2.94 - $4.08 $46,207 - $64,125	15,717 New	15,717 $50,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $482M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.